Measles Elimination Status in the US Under Review as Cases Surge
The United States could lose its “measles eliminated” status, a designation held since 2000, due to significant outbreaks in 2025 and continuing into 2026. The Pan American Health Organization (PAHO), a regional branch of the World Health Organization, has delayed a review of the US’s elimination status until November to allow for more comprehensive analysis.
What Does “Measles Eliminated” Mean?
Measles elimination doesn’t mean the disease is eradicated. It signifies that the virus is no longer continuously spreading within a country for more than one year. Whereas, imported cases can still occur, and outbreaks can happen if enough people are susceptible.
Why the Delay in Review?
Originally scheduled for April 13th, the PAHO review has been postponed to coincide with the organization’s annual meeting in November. This delay is attributed to the extensive analysis underway by US authorities, including complete virus genome sequencing and the development of a bioinformatics pipeline, alongside ongoing outbreak response efforts. PAHO aims to “simplify and standardize the assessment process” with this change.
Rising Case Numbers Fuel Concerns
The US has already reported over 1,100 measles cases in the first two months of 2026 – approximately six times the typical number for an entire year since elimination was declared. If the current pace continues, 2026 could surpass the nearly 2,300 cases reported in 2025.
A major outbreak originating in West Texas on January 20, 2025, is central to the review. If this outbreak is linked to other cases, including one currently in South Carolina, the US could lose its elimination status.
Mexico Also Facing Outbreak Challenges
The US isn’t alone. Mexico is also experiencing a deadly measles outbreak, and PAHO is reviewing data from both countries. The timeline for assessing elimination status remains unchanged for Mexico, focusing on transmission continuing for a full year after the start of the outbreak on February 1, 2025.
PAHO and CDC Collaboration
The US Centers for Disease Control and Prevention (CDC) is actively collaborating with PAHO, providing laboratory testing, technical assistance, and coordinating with state and local partners. PAHO has agreed to maintain the regular verification cycle.
Regional Trends: A Wider Problem
The Americas region as a whole saw a significant increase in measles cases in 2025, with 14,891 confirmed cases reported across 13 countries – a 32-fold increase compared to 2024. In the first three weeks of 2026, an additional 1,031 cases were confirmed in seven countries, representing a 43-fold increase over the same period in 2025. A large proportion of these cases, 78%, occurred in unvaccinated individuals, and 11% had an unknown vaccination status.
FAQ
Q: What is PAHO’s role in measles elimination?
A: PAHO provides technical guidance, monitors epidemiological data, and supports countries in strengthening immunization programs and outbreak response.
Q: What happens if the US loses its measles elimination status?
A: It indicates that the virus is circulating endemically within the country, increasing the risk of outbreaks and complications.
Q: How effective is the measles vaccine?
A: The measles vaccine is highly effective, providing protection with two doses.
Q: What countries are currently experiencing measles outbreaks?
A: In 2025, outbreaks were reported in Argentina, Belize, Bolivia, Brazil, Canada, Costa Rica, El Salvador, Guatemala, Mexico, Paraguay, Peru, the United States, and Uruguay. In early 2026, cases were confirmed in Bolivia, Canada, Chile, Guatemala, Mexico, and Uruguay.
Pro Tip: Ensure you and your family are up-to-date on all recommended vaccinations, including the MMR (measles, mumps, and rubella) vaccine.
Learn more about measles from the Pan American Health Organization and the Centers for Disease Control and Prevention.
What are your thoughts on the rising measles cases? Share your concerns and experiences in the comments below!
